Introduction:

ulcerative colitis is a chronic, inflammatory, ulcerative and relapsing disease of the gastrointestinal tract, which evolves by relapses.

Objective:

to determine the effectiveness of alternative treatment with stem cells in patients diagnosed with ulcerative colitis at Abel Santamaria Cuadrado General Teaching Hospital, Pinar del Rio province in the period of 2018-2020.

Methods:

a descriptive, longitudinal and prospective study was conducted. The target group consisted of 425 patients and the sample comprised 135 patients with a diagnosis of ulcerative colitis who met the inclusion criteria. Individual medical records were reviewed.

Results:

the age group 45-54 years (44 %) and female sex (59,25 %) predominated. Poor dietary habits (65,1 %), medication intake (40 %) and smoking (32,5 %) predominated, as well as a family history of ulcerative colitis (48.1 %). Mucous bloody stools (65,1 %), rectorrhagia (48,1 %) and abdominal pain (23,7 %) predominated, as well as the endoscopic method (69,6 %). A satisfactory evolution (93,5 %) was observed with the application of stem cell therapy.

Conclusions:

female sex and the age group 45-54 years were predominant. The main risk factors were poor dietary habits and medication intake. Ulcerative colitis predominated as a family pathological history. Mucous bloody stools, rectorrhagia and abdominal pain were the most relevant symptoms. The endoscopic procedure was the most important method and the effectiveness of the alternative method with autologous stem cells was demonstrated.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )